M

Myungmoon Pharm Co Ltd
KRX:017180

Watchlist Manager
Myungmoon Pharm Co Ltd
KRX:017180
Watchlist
Price: 1 826 KRW 0.05% Market Closed
Market Cap: 62B KRW

Wall Street
Price Targets

Price Targets Summary
Myungmoon Pharm Co Ltd

There are no price targets for Myungmoon Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Myungmoon Pharm Co Ltd Competitors:
Price Targets
WVE
WAVE Life Sciences Ltd
84% Upside
CRMD
CorMedix Inc
55% Upside
4540
Tsumura & Co
7% Upside
XLY
Auxly Cannabis Group Inc
76% Upside
000100
Yuhan Corp
26% Upside
300558
Betta Pharmaceuticals Co Ltd
39% Upside
000661
Changchun High & New Technology Industries Group Inc
41% Upside

Revenue
Forecast

Revenue Estimate
Myungmoon Pharm Co Ltd

For the last 13 years the compound annual growth rate for Myungmoon Pharm Co Ltd's revenue is 3%. The projected CAGR for the next 5 years is -5%.

3%
Past Growth
-5%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Myungmoon Pharm Co Ltd

For the last 13 years the compound annual growth rate for Myungmoon Pharm Co Ltd's operating income is -13%.

-13%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Myungmoon Pharm Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Myungmoon Pharm Co Ltd's stock price target?
Not Available

Myungmoon Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Myungmoon Pharm Co Ltd's Revenue forecast?
Projected CAGR
-5%

For the last 13 years the compound annual growth rate for Myungmoon Pharm Co Ltd's revenue is 3%. The projected CAGR for the next 5 years is -5%.

Back to Top